Phoenix MIS system allows the percutaneous placement of pedicle screws designed to offer stabilization and correction to aid fusion in patients suffering from degenerative disc disease, spinal stenosis and trauma conditions in the middle and lower back.
Featuring an advanced implant design for percutaneous and mini open surgical approaches, the system allows a smaller working diameter to reduce the surgical incision.
Healthcare market research firm GlobalData has estimated that spinal fusion market is expected to reach around $684m by 2020 in Japan.
Orthofix Spine Fixation president Ray Fujikawa said: “The Japanese approval and full market launch of the Phoenix MIS fixation system represents an important step towards broadening the availability of our spine fixation products globally by entering the second largest spine market in the world.
"We are committed to continuing to work towards securing additional product approvals in order to provide surgeons in Japan with a full range of our spine fixation solutions."
Based in Lewisville of Texas, Orthofix provides reconstructive and orthopedic and spine solutions to physicians.
The company operates four strategic business units, including biostim, biologics, extremity fixation and spine fixation.
In addition, the firm carries out research and development activities with clinical organizations such as the Musculoskeletal Transplant Foundation and the Texas Scottish Rite Hospital for Children.
